News that combining chemotherapy with immunotherapy can help extend the lifespan of triple-negative breast cancer patients offers hope for those inflicted with this aggressive and hard-to-treat cancer.
It is a breakthrough for immunotherapy as breast cancer was thought to be unresponsive to the body's immune system.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
